Literature DB >> 27107074

Bone Marrow Mesenchymal Stem Cells Reverse Liver Damage in a Carbon Tetrachloride-induced Mouse Model of Chronic Liver Injury.

Maorong Wang1, Xin Zhang2, X I Xiong2, Zhiguo Yang2, Ping Li2, Jie Wang2, Y U Sun3, Zhijian Yang4, Robert M Hoffman5.   

Abstract

BACKGROUND/AIM: The aim of this study was to investigate the effect of bone-marrow mesenchymal stem cells (BMSCs) on repair of liver damage in a carbon tetrachloride (CCl4)-induced mouse model of chronic liver damage.
MATERIALS AND METHODS: Green fluorescent protein (GFP)-expressing BMSCs, isolated from GFP transgenic mice, were transplanted into mice with chronic liver damage induced by CCl4 The GFP-expressing BMSCs in livers were detected by fluorescence microscopy. Serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were measured for assessment of liver function. Liver histopathology was performed to assess liver damage. mRNA and protein expression of liver-associated markers albumin (Alb) and alpha-fetoprotein (Afp) were detected to confirm the hepatic differentiation of BMSCs in the liver. Immunostaining for the expression of interleukin-10 (IL-10) and matrix metallopeptidase-9 (MMP-99), and enzyme-linked immunosorbent assay for the secretion of type III collagen and lamininin was carried out.
RESULTS: After BMSC transplantation, GFP-expressing BMSCs were detected in the peri-portal and injured areas of the CCL4-injured liver. mRNA and protein expressions of Alb and Afp were significantly increased in BMSC-transplanted liver. Mice treated with BMSCs displayed reduced serum levels of ALT and AST, and CCl4-induced histopathological changes in livers were repaired. BMSC transplantation increased the production of IL-10 and inhibited the expression of MMP-9, as well as the secretion of type III collagen and lamininin.
CONCLUSION: BMSCs transplanted into mice can migrate into damaged liver, differentiate into hepatocytes and promote recovery from chemically-induced liver damage. Promotion of IL-10 and inhibition of MMP-9 by transplanted BMSCs may be involved in the anti-inflammatory and anti-fibrotic action of BMSCs.
Copyright © 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Bone marrow; CCl4; liver damage; mesenchymal stem cells; mouse model; repair; transplantation

Mesh:

Substances:

Year:  2016        PMID: 27107074

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  12 in total

1.  The Therapeutic Potential of Extracellular Vesicles Versus Mesenchymal Stem Cells in Liver Damage.

Authors:  Dina M Rostom; Noha Attia; Hoda M Khalifa; Maha W Abou Nazel; Eshrak A El Sabaawy
Journal:  Tissue Eng Regen Med       Date:  2020-06-06       Impact factor: 4.169

2.  Exosomes from mesenchymal stem cells induce the conversion of hepatocytes into progenitor oval cells.

Authors:  Hao-Hsiang Wu; Oscar K Lee
Journal:  Stem Cell Res Ther       Date:  2017-05-23       Impact factor: 6.832

3.  Paracrine Effects of Bone Marrow Mononuclear Cells in Survival and Cytokine Expression after 90% Partial Hepatectomy.

Authors:  Carlos Oscar Kieling; Carolina Uribe-Cruz; Mónica Luján López; Alessandro Bersch Osvaldt; Themis Reverbel da Silveira; Ursula Matte
Journal:  Stem Cells Int       Date:  2017-02-23       Impact factor: 5.443

4.  Transplantation of human matrix metalloproteinase-1 gene-modified bone marrow-derived mesenchymal stem cell attenuates CCL4-induced liver fibrosis in rats.

Authors:  Chao Du; Mingde Jiang; Xiaolong Wei; Jianpin Qin; Hui Xu; Yunxia Wang; Yong Zhang; Dejiang Zhou; Hongli Xue; Shumei Zheng; Weizheng Zeng
Journal:  Int J Mol Med       Date:  2018-02-27       Impact factor: 4.101

5.  Autologous bone marrow cell transplantation in the treatment of HIV patients with compensated cirrhosis.

Authors:  Baochi Liu; Mingrong Cheng; Xiaodong Chen; Lei Li; Yanhui Si; Shijia Wang; Ying Wang; Yufang Shi
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

Review 6.  Pluripotent-Stem-Cell-Derived Hepatic Cells: Hepatocytes and Organoids for Liver Therapy and Regeneration.

Authors:  Antonietta Messina; Eléanor Luce; Marwa Hussein; Anne Dubart-Kupperschmitt
Journal:  Cells       Date:  2020-02-12       Impact factor: 6.600

7.  Single cell Raman spectroscopy to identify different stages of proliferating human hepatocytes for cell therapy.

Authors:  Chen Ma; Ludi Zhang; Ting He; Huiying Cao; Xiongzhao Ren; Chenhui Ma; Jiale Yang; Ruimin Huang; Guoyu Pan
Journal:  Stem Cell Res Ther       Date:  2021-10-30       Impact factor: 6.832

8.  Intravenous Umbilical Cord-derived Mesenchymal Stem Cells Transplantation Regulates Hyaluronic Acid and Interleukin-10 Secretion Producing Low-grade Liver Fibrosis in Experimental Rat.

Authors:  Taufik Sungkar; Agung Putra; Dharma Lindarto; Rosita Juwita Sembiring
Journal:  Med Arch       Date:  2020-06

9.  Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6/STAT3 signaling pathway in CCl4-induced rat liver fibrosis.

Authors:  Shimaa Farouk; Salwa Sabet; Fatma A Abu Zahra; Akmal A El-Ghor
Journal:  PLoS One       Date:  2018-10-22       Impact factor: 3.240

10.  Bone Marrow-Derived Mesenchymal Stem Cell Potential Regression of Dysplasia Associating Experimental Liver Fibrosis in Albino Rats.

Authors:  Yasmine H Khalifa; Ghada M Mourad; Wahid M Stephanos; Sahar A Omar; Radwa A Mehanna
Journal:  Biomed Res Int       Date:  2019-11-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.